Bristol Myers Squibb
Princeton, NJ, United States
Jinqi (Jane) Liu, Ph.D.
Bristol Myers Squibb (Princeton)
INDUSTRIAL AND PROFESSIONAL EXPERIENCE:
Jan 2017-present Bristol Myers Squibb
Clinical biomarker lead in translational medicine for immunological diseases
Senior Principal Scientist in the discovery area of Immuno-oncology
• Disease area: Immuno-oncology, Oncology, Immunology
Nov 2009 –Dec 2016 Merck Research Laboratories
Director/Principal Scientist in the area of discovery/translational biology,
• Disease Area: Oncology, Fibrosis, Diabetes, Obesity
2008-2009 Ligand Pharma
Senior Principal Investigator/Group Leader,
• Disease area: Autoimmunity
2000-2008 Pharmacopeia Inc.
Senior Principal Scientist/Principal Scientist/Senior Scientist/Senior Research Scientist,
• Disease area: Rheumatoid arthritis, Inflammatory Bowel Disease, Oncology and related angiogenesis
1998-2000 Eli Lilly and Company.
Postdoctoral Fellow,
• Disease area: autoimmune and graft vs host diseases
1995-1998 University of Texas at Austin
• Disease area: T cell leukemia and mammary cancer
EDUCATION
Ph.D, Cancer immunology. Department of Microbiology and Institute of Cellular and Molecular Biology,
University of Texas at Austin, Austin, TX
M.S. Academia Sinica, Beijing, China.
B.S. Department of Biology, Northeastern University, Shenyang, China.
Disclosure information not submitted.
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
